With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
Working as part of a strong, unified people team, the People Co-ordinator is a central role designed to support the Senior People Co-ordinator, in conjunction with the People Partnering team to deliver a best in class people experience. The key focus will be delivering administrative support to the people team and organisation by way of efficient and effective administration service.
Working closely with the Senior People Co-ordinator you will be involved in timely and accurate onboarding for new hires from drafting contracts to organising the onboarding day/calendar, keeping our systems up to date and accurate so we can provide reports and analysis as required, responding to initial employee and manager queries about benefits, policies or general HR queries, and escalating as required. You will also work closely with the team on improving and streamlining our processes and policies to be more efficient or to better serve our colleagues and organisation.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.